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How the genome activates or silences transcriptional programmes governs organ formation.
Little is known in human embryos undermining our ability to benchmark the fidelity of stem
cell differentiation or cell programming, or interpret the pathogenicity of noncoding variation.
Here, we study histone modifications across thirteen tissues during human organogenesis.
We integrate the data with transcription to build an overview of how the human genome
differentially regulates alternative organ fates including by repression. Promoters from nearly
20,000 genes partition into discrete states. Key developmental gene sets are actively
repressed outside of the appropriate organ without obvious bivalency. Candidate enhancers,
functional in zebrafish, allow imputation of tissue-specific and shared patterns of transcrip-
tion factor binding. Overlaying more than 700 noncoding mutations from patients with
developmental disorders allows correlation to unanticipated target genes. Taken together, the
data provide a comprehensive genomic framework for investigating normal and abnormal
human development.
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Organogenesis is the key phase when the body’s tissues andorgans are first assembled from rudimentary progenitorcells. In human embryos, this is the critical period during
weeks 5–8 of gestation when disruption can lead to major
developmental disorders. While ~35% of developmental disorders
are explained by damaging genetic variation within the exons of
protein-coding genes1, de novo mutation (DNM) in the non-
coding genome has been associated increasingly with major
developmental disorders2. The non-coding genome also harbours
over 80% of single-nucleotide polymorphisms (SNPs) implicated
in genome-wide association studies (GWAS) for developmental
disorders, or in GWAS of later onset disease, such as schizo-
phrenia and type 2 diabetes, where contribution is predicted from
early development3. These genetic alterations are presumed to lie
in enhancers for developmental genes or in other regulatory
elements, such as promoters for non-coding RNAs that may only
be active in the relevant tissue at the appropriate stage of orga-
nogenesis. Aside from rare examples4, this has remained unpro-
ven because of lack of data in human embryos. While regulatory
data are available in other species at comparable stages5, extra-
polation is of limited value because the precise genomic locations
of enhancers are poorly conserved6,7 even allowing for enriched
sequence conservation around developmental genes8,9. Sequence
conservation alone is also uninformative for when and in what
tissue a putative enhancer might function. Comprehensive reg-
ulatory information is available from later fetal development via
initiatives such as NIH Roadmap10, but these later stages largely
reflect terminally differentiated, albeit immature cells rather than
progenitors responsible for organ formation. In contrast, a small
number of studies on a handful of isolated tissues, such as limb
bud11, craniofacial processes12, pancreas13, or brain14, have
demarcated regulatory elements directly during human organo-
genesis. However, most organs remain unexplored. Moreover,
nothing is known about patterns of regulation, including both
activation and repression, deployed across tissues, which is an
important factor because tissues are often co-affected in devel-
opmental disorders. To address these gaps in our knowledge, we
set out to build maps of genome regulation integrated with
transcription during human organogenesis at comprehensiveness
currently unattainable from single-cell analysis.
Results
Assembly of datasets across 13 tissues. Thirteen different types
of organs and tissues were contributed by 61 human post-
implantation embryos, microdissected and subjected to chroma-
tin immunoprecipitation followed by deep sequencing (ChIPseq)
for three histone modifications (Fig. 1a): H3K4me3, enriched at
promoters of transcribed genes; H3K27ac, at active enhancers and
some promoters; and H3K27me3 delineating regions of the
genome under active repression by Polycomb. Tiny tissue size
and the scarcity of human embryonic tissue required some
pooling and precluded study of additional modifications. Biolo-
gical replicates were undertaken for all but two tissue sites (details
are in Supplementary Data 1 and 2). These all included both male
and female tissue. Tissues and stages were matched to poly-
adenylated RNAseq datasets acquired at sufficient read depth to
identify over 6000 loci with previously unannotated transcription
(Supplementary Data 3)15. Overlaying the data revealed char-
acteristic tissue-specific patterns of promoter and putative
enhancer activity, and unannotated human embryonic tran-
scripts. This was particularly noticeable surrounding genes
encoding key developmental transcription factors (TFs), such as
the example shown for NKX2-5 in the heart (Fig. 1b). Tissues
lacking expression of the TF gene tended to carry active
H3K27me3 modification rather than simply lack marking.
Putative tissue-specific enhancer marks were characteristically
distributed over several hundred kilobases (heart-specific peak
(red) over 200 kb from NKX2-5 to the far right of Fig. 1b). These
isolated H3K27ac marks were often unpredicted by publicly
available data from cell lines or terminally differentiated lineages
and did not necessarily show sequence conservation across ver-
tebrates (mean per-base phyloP score 0.175; range −1.42 to
+6.94 for n= 51,559 regions)16. Unexpected H3K4me3 and
H3K27ac peaks that failed to map to the transcriptional start sites
(TSSs) of annotated genes mapped to the TSS of previously
unidentified human embryo-enriched transcripts, such as the
example shown in Fig. 1b for the bidirectional HE-TUCP-C5T408
and HE-LINC-C5T409 (for the complete catalogue see Supple-
mentary File 1H in ref. 15). Recognising the importance of fea-
tures surrounding key developmental genes such as NKX2-5, all
the individual data are available to browse as tracks on the UCSC
Genome Browser. These preliminary observations encouraged us
to undertake full integration of the different datasets to enable a
series of genome-scale analyses.
Major promoter states partition without obvious bivalency. By
analysis based on a Hidden Markov Model, the genome parti-
tioned into different chromatin states very similarly across tis-
sues17. While three histone marks allowed for eight different
segmentations, aggregation into fewer states was possible
(Fig. 1c). On average across tissues, 3.3% of the genome was
active promoter (States 1 & 2; H3K4me3+ /− H3K27ac) or
putative enhancer (State 3; H3K27ac) (range 1.7–6.1%; Fig. 1c &
Supplementary Fig. 1). In all, 6.7% was variably marked as
actively repressed (States 6 & 7; range 3.3–13.0; H3K27me3),
while on average 89.8% of the genome was effectively unmarked
(States 4 & 5; range 81.7–94.0). Approximately 0.2% seemingly
had both H3K4me3 and H3K27me3 marks (State 8; range
0.16–0.33). This latter state has been considered bivalent and
characteristic of poised genes whose imminent expression then
initiates cell differentiation pathways18–20. Ascribing bivalency
has been reliant on setting an arbitrary threshold for a binary
decision of whether a site is marked or not. This risks the
impression of equivalence when in fact one or other mark might
be far more prominent. Moreover, apparent bivalency could
simply reflect mixed marks due to heterogeneity in a cell popu-
lation (the minor co-detection of H3K27ac in State 8 would not
be expected in the presence of H3K27me3). Taken together, this
reliance on an arbitrary threshold is suboptimal. Therefore, we
used ngsplot to cluster promoter profiles for each histone mark
integrated with transcription over 3 kb either side of 19,791 dis-
tinct protein-coding TSS in each tissue21 (Fig. 2; Supplementary
Figs. 2–4). We started under default settings for three histone
modifications and RNA-seq, which generated the five most pro-
minent clusters. Broader H3K4me3 and H3K27ac signals at the
TSS correlated with higher levels of transcription (Fig. 2a–b; we
termed this promoter state broad expressed versus narrow or
bidirectional expressed). In total, 25–30% of genes across tissues
were unmarked and lacked appreciable transcription (inactive).
These promoters typically lacked CpG islands (<20% compared
with 67.7% of the 19,791 genes). Conversely, 90–95% of TSS
regions marked with H3K27me3 featured CpG islands with an
over-representation of TFs; 31.2% of TFs (n= 1659) were actively
repressed in at least one tissue compared with 20.0% of non-TF
genes (odds ratio 1.82, confidence interval 1.63–2.04; P-value
< 2.2e-16). H3K27me3 detection at the TSS was ~50% greater for
genes encoding TFs (Supplementary Fig. 5). The categorisation
for each of the 19,791 genes in all tissues is listed in Supplemen-
tary Data 4. When prioritised under default settings, patterns
across tissues were strikingly similar with only minor variation in
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bidirectional transcription in RPE (Supplementary Fig. 2) and a
technical factor limiting the detection of expression at the TSS for
particularly long transcripts in the liver, lung and brain (Sup-
plementary Figs. 3 and 4). Consistently, neat partitioning would
not have been possible if the data were overly confounded by
cellular heterogeneity. While a major bivalent chromatin state at
gene promoters was not detected under these parameters, it was
noticed that H3K4me3 levels were slightly higher in the active
repression group than for inactive genes (Fig. 2b, H3K4me3, red
and grey lines, respectively). H3K27ac signal for active repression
and inactive virtually overlapped, very close to the background
signal. Therefore, we extended the ngsplot parameters to allow
more subcategorization in the search for bivalency. Explicitly, we
wanted to see if we could split the H3K27me3 signal into a subset
of characteristic bivalent genes with clear cut H3K4me3. Seven
(kidney), eleven (liver), or ten categories (all other replicated
tissues) split the H3K27me3 signal. For each tissue, the smaller
H3K27me3 sub-category now clustered with weak detection of
H3K4me3 (and some low-level transcription). We assessed
enrichment of these genes in each tissue for putative bivalent
characteristics, such as imprinting or TFs characteristic of the
particular tissue fate. However, in all instances the same generic
categories, such as extracellular matrix organisation, receptor
tyrosine kinases and a variety of neural terms emerged. Supple-
mentary Figs. 6–11 show examples for the adrenal, kidney and
pancreas. These categories and the genes underlying them are
well-recognised to reflect mesenchyme and neural development
as has been detailed for the pancreas22 with characteristic WNT
and FGF family members23. In summary, promoter regions
partitioned neatly into major chromatin states allied to
Brain
a
RNAseq
+
ChlPseqRetinal pigmented
epithelium
Palate
Tongue
Upper limb
Heart (left ventricle)
Stomach
Pancreas
Lower limb
Lung
Liver
Adrenal
Kidney
Novel HE
transcripts
HE-LINC-C5T407
HE-TUCP-C5T408
HE-LINC-C5T409
HE-TUCP-C5T410
STC2
100 kb
HE-LINC-C5T411
NKX2-5
RNAseq
(Heart/LV)
–
+
H3K4me3
H3K27ac
H3K27me3
ENCODE
Vert. conservation
Genome coverage (%)1
2
3
4
Ch
ro
m
HM
M
 s
ta
te
5
6
7
8
H3
K2
7a
c
H3
K4
me
3
H3
K2
7m
e3
Sate 4+5
State 6+7
State 1
State 2
State 3
State 8
H3K27ac
H3K4me3
H3K27me3
Integrative analysis
Regulatory patterns
governing
human organogenesis
b
c
Fig. 1 Epigenomic landscape across 13 human embryonic tissues. a Thirteen different human embryonic sites were sampled for RNAseq15 and ChIPseq, as
described in the “Methods” and in Supplementary Data 1 and 2. The same colour coding for each tissue is applied throughout the paper in overlaid ChIPseq
tracks. The heart (left ventricle) dataset is summarised as Heart/LV from hereon. b 300 kb locus around the NKX2-5 gene, the most discriminatory TF
gene for human embryonic heart15. The locus contains five unannotated human embryonic (HE) transcripts enriched in heart [three LINC RNAs and two
transcripts of uncertain coding potential (TUCP)]. Heart/LV-specific (red) H3K4me3 and H3K27ac marks were detected at the NKX2-5 TSS and adjacent
transcripts (HE-TUCP-C5T408 and HE-LINC-C5T409). Embryonic heart-specific H3K27ac marks were visible up to 200 kb away (e.g., at the extreme right
of panel). H3K27me3 marked the region from NKX2-5 to HE-LINC-C5T409 in all non-heart tissues (the track appears black from the superimposition of all
the different colours other than red). ENCODE data are from seven cell lines26. c Genome coverage by ChromHMM for the different histone modifications
was similar across all tissues (Supplementary Fig. 1) with an average 89.8% of the genome unmarked (range: 81.7–94.0; States 4 & 5), and 3.3% consistent
with being an active promoter and/or enhancer (range: 1.7–6.1; States 1–3).
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transcription. Sets of bivalent genes were not observed before
gene sets indicative of cell-types common across all tissues limited
the extent of subcategorization.
Mapping major promoter states discovers disallowed gene sets.
Our classification allowed us to ask how the major promoter
states changed across different tissues. Tracking all states in all
tissues was complex to visualise (Supplementary Fig. 12). Uni-
fying broad, narrow and bidirectional expressed into a single
category (expressed) displayed how the majority of genes
remained unaltered across tissues (Fig. 3a). In contrast, 29% of
genes had a variable promoter state. Within this subset, we pre-
dicted that genes responsible for a specific organ’s assembly, such
as those encoding developmental TFs, would need to be actively
excluded or disallowed at inappropriate sites (as seen in Fig. 1b
for NKX2-5). We tested this in the replicated datasets by com-
paring genes transcribed uniquely in one tissue for either inac-
tivity (no mark) or active repression elsewhere (H3K27me3;
disallowed). Gene ontology (GO) analysis of the uniquely
expressed/disallowed elsewhere gene sets identified the appro-
priate developmental programme in all instances (as shown for
the heart in Fig. 3b; e.g., heart development). These gene sets are
listed for each tissue in Supplementary Data 5a. In contrast,
tissue-specific transcription initiated from genes that were simply
inactive in other organs tended to highlight differentiated cell
function (Fig. 3b; e.g., sarcomere organisation). These observa-
tions highlight the preferential use of H3K27me3 at the
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Fig. 2 Classification of major promoter states. a Clustered heatmaps surrounding the transcriptional start sites (TSS+ /− 3 kb) of 19,791 annotated
genes. The example shown is for adrenal. One replicate is shown for each data type for simplicity. Replicates across all tissues were near identical. Two
minor variations on this pattern were detected in RPE (Supplementary Fig. 2) and the liver, lung and brain (Supplementary Fig. 3). b Mean signal levels for
the genes clustered in (a). Traces are coloured according to the text colour in (a). Broad expressed genes show approximately double the level of
transcription and twice the width of H3K4me3 and H3K27ac marks compared with narrow expressed genes.
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promoters of genes controlling cell fate decisions, but not dif-
ferentiated function. Moreover, the fact that these cell fate genes
did not emerge for any tissue in the sub-categorisation of
H3K27me3 signal with low-level H3K4me3 (Supplementary
Figs. 6–11) further supports lack of bivalency at their gene
promoters.
To scrutinise regulatory changes temporally, we focussed on
pancreas and included datasets from human pluripotent stem
cells (hPSCs) and adult tissue. Different sets of repressed genes
lost their H3K27me3 mark to become expressed as cells
transitioned from pluripotency to embryonic pancreatic progeni-
tors or from pancreatic progenitors to mature pancreas (Fig. 3c;
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Fig. 3 Integration of promoter states across tissues and over time. a Alluvial plot showing promoter state for 19,791 annotated genes across all tissues
with replicated datasets. To aid visualisation, all the different transcribed states are amalgamated into a single expressed category (the alluvial plot for all
individual states is shown in Supplementary Fig. 6). The example shown is centred on the promoter state in the Heart/LV dataset. Those genes with an
expressed promoter state in the heart and either active repression or inactive elsewhere are indicated to the right of the panel and subject to gene
enrichment analyses in (b). b Gene enrichment analysis of genes with an expressed promoter state in the heart and either active repression or inactive in
all remaining tissues. All remaining genes were used as background. Examples of the genes underlying the biological process (BP) or disease ontology
(DO) terms and their total number are listed beneath the bar charts. c Alluvial plot showing the variance in promoter state between H1 human pluripotent
stem cells (hPSCs), the embryonic pancreas (prior to endocrine differentiation24) and the adult pancreas. Circles capture those genes that shift from active
repression to expressed at the stage of either embryonic or adult pancreas. d Gene enrichment analyses of encircled genes from (c). Examples of the genes
underlying the BP and KEGG terms and their total number are listed beneath the bar charts. All remaining genes were used as background. While maturity
onset diabetes of the young emerged in both analyses, the underlying genes were different reflecting developmental roles prior to or after pancreatic
endocrine differentiation24.
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genes are listed in Supplementary Data 5b). Surprisingly, the
same KEGG term relating to monogenic diabetes emerged in both
instances (Fig. 3d). However, the genes underlying the first
transition related to early function in pancreatic organogenesis,
hypoplasia, or aplasia (e.g., GATA6, SOX9 and PDX1); while the
genes in the second transition specifically related to post-
embryonic pancreatic islet cell differentiation and beta-cell
function (e.g., INSM1, MAFA and NKX2-2)24,25.
Human regulatory sequences function in zebrafish embryos.
Having recognised the disallowed status of developmental TFs in
inappropriate tissues, we wanted to test whether our putative
intergenic human embryo-enriched enhancers were capable of
driving appropriate reporter gene expression at the correct loca-
tions in developing zebrafish. We identified H3K27ac marks that
were enriched in the human embryo compared with 161
ENCODE or NIH Roadmap datasets10,26 and not detected in the
FANTOM5 project27. We developed an algorithm to test for
embryonic tissue specificity and filtered for sequence conserva-
tion (not necessarily in zebrafish; see “Methods”). We manually
inspected the remainder for proximity (<1 mb) to genes encoding
TFs and, in particular, to increase clinical relevance, to those
associated with major developmental disorders. We ensured no
H3K4me3 or polyadenylated transcription in the immediate
vicinity (i.e., an unannotated promoter). We tested 10 such
enhancers out of 44 within 1 mb of TBX15, HEY2, ALX1, IRX4,
PITX2, HOXD13, NKX2-5, WT1, SOX11 and SOX9 for their
ability to direct appropriate GFP expression in stable lines of
transgenic zebrafish (Supplementary Data 6). Two (h-003-kid
nearWT1 and h-022-mix near SOX11) failed to generate any GFP
in any location. The remaining eight all yielded GFP at the pre-
dicted site in zebrafish embryos (Fig. 4; Supplementary Data 6),
despite only one of the putative enhancer sequences being con-
served in zebrafish (Fig. 4a, h-027-lim near TBX15). Taken
together, these data imply that our H3K27ac detection marks
previously unannotated human enhancers, which function over
considerable evolutionally distance, despite the absence of
detectable sequence conservation. This is most likely associated
with overall conservation of TF activity between homologous
organs across species28.
Patterns of H3K27ac modification are unique across tissues.
We wanted to explore the link between these regulatory elements
and surrounding gene expression at genome-wide scale. Assured
that ChIPseq marks were reproducible within biological replicates
without batch effect (Supplementary Fig. 13), we parsed the
genome into 3,087,584 non-overlapping 1 kb bins. Reads within
each bin were counted for each mark. Phi correlation between
biological replicates indicated this approach to peak calling was
very similar to using MACS (Supplementary Fig. 14). Counts
were downsampled and averaged within tissues and correlated
with the corresponding RNAseq data over 1 mb in either direc-
tion (i.e., a 2 mb window). On average, this window included 44
annotated genes (range: 0–247 genes). For those H3K27ac marks
which functioned in zebrafish, the strongest correlation was with
the appropriate TF gene, for instance TBX15 over ~500 kb in limb
(Fig. 4a). Moreover, within the 2 mb window, different H3K27ac
marks could be correlated to the same gene, potentially allowing
previously unknown enhancers to be grouped, for instance in the
adrenal around the adrenal hypoplasia gene, NR0B1, located on
the X chromosome (Supplementary Fig. 15).
Parsing the ChIPseq data into bins allowed integration of
information across tissues, which is challenging when based on
empirical modelling by MACS. Placing raw read counts per bin in
rank order produced near identical elbow plots for all marks in all
tissues. This avoided arbitrary assignment and allowed the point
of maximum flexure to be used quantitatively for calling marks in
a binary yes/no fashion (Fig. 5a). The simplified calling facilitated
exploration of regulatory patterns across tissues. Requiring a bin
to be marked in any two or more samples identified 48,570
different H3K27ac patterns genome wide. The top 40 are shown
in Fig. 5b. While tissue specificity for the heart/left ventricle was
the most common pattern, all replicated organs ranked within the
top 0.6% of patterns. Nine out of the 11 replicated tissues ranked
in the top 0.2% (Supplementary Data 7). These data indicate high
reproducibility and consistency across tissue replicates. H3K27ac
showed far more tissue-selective patterns than H3K4me3 or
H3K27me3 (Fig. 4b; Supplementary Figs. 16 and 17). Motif
analysis on the tissue-specific H3K27ac regions allowed imputa-
tion of master TFs for individual tissues, such as NR5A1 in 54.5%
of adrenal-specific bins (n= 18,411) compared to 25% of the
remaining 141,706 bins (Fig. 5c). Mutation of NR5A1 causes
adrenal agenesis in human and mouse (OMIM 184757). MEF,
TBX and bHLH family members emerged in the heart-specific
bins (Fig. 5c); all are associated with congenital heart disease29.
This emergence of TFs with known, critical tissue-specific
functions underscores the validity of parsing the ChIPseq data
into bins as well as the consistency of data between tissue
replicates.
Having integrated our data, we could also uncover regulatory
regions that were shared precisely across two or more tissues
relevant to developmental disorders which manifest in multiple
organs. Enrichment for composite PITX1/bHLH motifs was
found in the limb and palate (Fig. 5c). GATA-binding motifs
were enriched in the heart and pancreas. Shared patterns could be
explicitly instructed by requiring detection in four or more
samples (Supplementary Fig. 18). We hypothesised that patterns
shared across many tissues ought to contain elements regulating
generic developmental functions. Scrutinising bins marked in
over half of all H3K27ac samples (n= 30,226 bins versus
remaining background of 80,352 bins) identified enrichment for
the ETS motif. ETS transcription factors are involved in cell cycle
control and proliferation30.
Overlaying the epigenomes with developmental disorders.
Non-coding mutations in promoters or enhancers have been
linked increasingly to major developmental disorders4,31. Pre-
viously, as part of the Deciphering Developmental Disorders
(DDD) study, we studied 7930 individuals and their parents32. In
all, 87% of patients had neurodevelopmental disorders. 10% had
congenital heart defects. 68% of patients lacked disease-associated
DNMs within exomes (exome-negative) pointing to the likely
importance of the non-coding genome2. We sequenced 6139
non-coding regions (4.2 mb) selected as ultra-conserved regions
(UCRs: n= 4307), experimentally validated enhancers (EVEs:
n= 595) or as putative heart enhancers (PHE: n= 1237) and
found 739 non-coding DNMs2. In total, 78% of the 6139 regions
were marked by H3K27ac or H3K4me3 in our embryonic tissues,
with a higher percentage overlap for the EVEs (87%) and near-
perfect overlap for the PHEs (99%) (Fig. 6a). An additional 9%
were marked by H3K27me3, suggesting non-coding regulation in
a currently unsampled tissue. The distribution of DNMs was very
similar (Fig. 6b). Nearly half of the regions containing DNMs
were marked by H3K27ac and/or H3K4me3 that was replicated
in at least one tissue. Most commonly, this included the heart or
brain, in keeping with the predominance of neurodevelopmental
and cardiac phenotypes in the DDD cohort and the PHEs selected
for sequencing (Fig. 6c). In total, 75% of the PHEs with DNMs
mapped to replicated H3K27ac and/or H3K4me3 in our heart
dataset. This rose to 100% if the need for replication was
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removed. We did not observe enrichment for DNMs in patients
with heart, eye or limb phenotypes in elements marked by
H3K27ac. Similarly, organ-level association with clinical pheno-
type was not possible. In both circumstances, the power of testing
was markedly curtailed by limitations in patient numbers
(Fig. 6d). Enrichment for DNMs in elements marked by H3K27ac
was detected with neurodevelopmental disorders (87% of the
DDD cohort; 1.45-fold, 95% confidence interval 1.09–1.90; P=
0.0056) (Fig. 6d). This was similar to our previous report using
NIH Roadmap H3K27ac and/or DNaseI hypersensitivity data
r = 0.82
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Fig. 4 Transgenic analysis of H3K27ac regions from human embryonic tissues. H3K27ac-marked regions were tested in multiple lines of stable
transgenic zebrafish (details in Supplementary Data 4; same colour coding of tracks as in Fig. 1). a 231 bp limb enhancer, 502 kb downstream of TBX15, with
the corresponding green fluorescent protein (GFP) detection in fin bud at 48 h post fertilisation (hpf). b About 355-bp heart/LV enhancer, 189 kb upstream
of HEY2, with the corresponding ventricular GFP detection at 48 hpf. c 1.5 kb palate enhancer, 141 kb downstream of ALX1, with GFP in the developing
trabecula and mandible (blue arrows) at 48 hpf. Correlations between the enhancer and transcription of the TF gene are shown for each example. Note the
H3K27me3 marks over the gene in each instance in other tissues. *, midbrain GFP expression from the integral enhancer in the reporter vector used as a
positive control for transgenesis.
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derived from second trimester fetal brain2. Our results support a
role for non-coding mutations in severe neurodevelopmental
disorders.
Prioritising individual DNMs for potential pathogenicity and
how they might disrupt surrounding gene function is very
challenging. We anticipate an atlas of human embryonic
regulatory marks comprising different tissues will help stratify
disease-relevant non-coding regions; and that correlation to
surrounding transcription offers a preliminary means for
prioritising putative target gene(s). We have made all correlations
freely available as tracks on the UCSC Genome Browser and
present two examples here as preliminary exemplars. A DNM
linked to neurodevelopmental disorders in a UCR on chromo-
some 16 is in the middle of the annotated testicular LINC RNA,
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LINC01572 (Fig. 7; chr16:72,427,838). Our data illustrate that the
DNM is also located at the TSS of HE-OT-AC004158.3, expressed
at 19.5-fold higher levels in human embryonic brain than any
other tissue (mean read count of quantile normalised transcripts
in the brain, 1317.2; mean in other tissues, 32.2), in a 4 kb region
of brain-specific H3K27ac (and to a lesser extent, H3K4me3).
Across 18 protein-coding genes in the region, the H3K27ac signal
was most highly correlated to expression of ZNF821 (r= 0.92)
550 kb away and anti-correlated to the adjacent gene, ATXN1L (r
=−0.65; Fig. 7). As a second example, a cardiac-specific
enhancer in the final intron of ATXN1 on chromosome 6
contained a DNM from the DDD cohort associated with
congenital heart disease (Fig. 8a). Across a 2.4 Mb region
surrounding this putative enhancer, expression of the gene,
RBM24, located ~1 mb away, was markedly enriched in heart
compared to other organs (Fig. 8b) and the gene most correlated
to the enhancer (r= 0.88). RBM24 is required for cardiac
development with knockout mice dying at E12.5-14.5 with
ventricular septal defects and compromised cardiac muscle
assembly33. We used CRISPR-Cas9 to delete the enhancer in
our established NKX2-5-GFP reporter hPSC model34,35 (Fig. 8c).
Cells were viable, but loss of the enhancer markedly curtailed the
generation of NKX2-5-positive cardiomyocyte progenitors
(Fig. 8d–e). This was associated with markedly reduced expres-
sion of RBM24, but not of other genes in the locus (Fig. 8f).
Taken together, we have assembled datasets of regulatory
activity linked to transcription for a range of human embryonic
tissues during the period of organogenesis. All data are available
to browse as tracks on the UCSC Genome Browser ready for
overlay with genetic variants identified by clinical sequencing
and GWAS.
Discussion
Previous studies of enhancer usage in human embryos have
tended to focus on individual tissues inferring, amongst other
findings, aspects of genome regulation responsible for human-
specific attributes11–14. Here, we incorporated epigenomic data
with transcription across 13 sites during human organogenesis to
build tissue-by-tissue maps of enhancers and promoters linked to
gene expression. While similar to prior work in mouse5 and
building on our previous transcriptomic atlas15, the integrated
approach here offers opportunities to understand how human
organ formation is regulated in health and disease.
It is important to draw out certain features of the study,
including limitations. The datasets comprised pooled tissue
samples across several embryos including both sexes. This
removed the opportunity for analysis of male or female tissue in
isolation; however, it mitigated against the risk of misinterpreting
organ-level differences that might be due to sex, for instance
related to H3K27me3 and X chromosome inactivation. Moreover,
the aggregated data across many embryos reduced the risk of
other misleading conclusions due to one-off biological or tech-
nical factors, such as deterioration during transport. Our tissue
collection and molecular analyses occur on a single campus with
immediate processing. For instance, in quality control, we have
found overnight delay in preservation media can lead to a 16-fold
decline in the levels of some key developmental TFs, despite tissue
remaining viable and suitable for immunohistochemistry and
subsequent tissue culture. It is also obvious that the bulk analyses
contain aspects of tissue heterogeneity, as we reached in all tissues
with our deeper analyses of promoter state (Supplementary
Figs. 6–11). However, the emergent features of our data such as
the gene ontology for major promoter states (Fig. 3b, d) and the
binding motifs within tissue-specific enhancers (Fig. 5c) indicate
the majority contribution from organ-specific progenitor cells.
Our past analysis based on variance also minimises any con-
tribution from cell-types common to all tissues15. While single-
cell technology allows deconvolution of organ-level heterogeneity,
at present the techniques do not permit the extent of analysis for
histone modification or transcription as we have undertaken here.
We envisage our integrated atlas will provide a valuable com-
plement to current and future single-cell analyses of human
organogenesis.
Assessing the non-coding genome is very challenging: millions
of rare variants are returned from whole-genome sequencing
(WGS) in each individual, while only one might be pathogenic36.
Although we provided proof-of-principle here for a cardiac
enhancer, functional analysis, even of a handful of variants, is
clinically impractical. For non-coding mutations to affect orga-
nogenesis (either in developmental disorders or in later life dis-
ease such as type 2 diabetes where there is an embryonic
contribution), it is logical that mutations are located in regulatory
regions of the genome that are active in post-implantation human
embryos. As evident from Fig. 1c, our identification of this
landscape offers a timely pipeline for stratifying 98.5% of the
genome down to 3% on average per tissue (States 1–3). At pre-
sent, the associations from our dataset to non-coding mutations
from patients is hampered by statistical power in the clinical
cohorts, potentially allied to aspects of ascertainment bias, for
instance towards neurodevelopmental disorders in DDD32. As
cost continues to decline, WGS will become an increasingly
important tool in main stream clinical investigation, opening up
potential genetic diagnoses in the 98.5% of the human genome
that lies outside of coding sequences. At this point, we anticipate
that our datasets will help to stratify disease-associated variants.
Enrichment of tissue-specific TF binding in these enhancers and
Fig. 5 Patterns of enhancer activity and transcription factor binding across tissues. a Elbow plots for each histone modification following allocation of the
genome into 3.1 million consecutive bins of 1 kb. The example shown is for adrenal providing the number of reads per bin at the point of maximum gradient
change (the elbow point, red dot) and a quantitative measure of whether a bin was marked or not (e.g., >10 or <10, respectively, for H3K27ac). Converting
marks into a binary yes/no call at any point in the genome facilitated the data integration across the different tissues. While the number of reads per bin at
the elbow point was different for each mark across the tissues, the shape of the curve remained the same. b Euler grid for bins marked by H3K27ac
(defined by elbow plots) in replicated tissues (i.e., two rows/replicates per tissue). Total number of marked bins per individual dataset is shown to the
right. The example in (b) required a bin to be called in any two or more samples and is ordered by decreasing bin count per pattern (bar chart above the
grid). A total of 48,570 different patterns were identified, of which the top 40 are shown. Tissue specificity for all sites emerged in the top 265 (0.5%)
patterns; colour-coded asterisks above columns). For example, nearly 14,000 bins marked only in the two Heart/LV H3K27ac datasets ranked first as the
most frequent pattern. The seventh most frequent pattern in ~3000 bins was palate-specific. Tissue-specific patterns were far less apparent at promoters
(H3K4me3, n= 18,432; Supplementary Fig. 10) or for H3K27me3 (n= 26,339; Supplementary Fig. 11). While patterns across multiple tissues were
permitted by stipulating marks in ≥2 samples (e.g., heart and adrenal in column 24), they could be enforced by stipulating marks in at least four samples
(Supplementary Fig. 12). c Enrichment of known TF-binding motifs in the tissue-specific patterns of H3K27ac identified in (b). Five individual tissues are
shown as examples alongside analysis of the shared regulatory pattern identified for the limb and palate identifying marked enrichment of a compound
PITX1:E-box motif. Motif-enrichment was conducted using a one-sided Binomial test implemented in findMotifsGenome.pl of the HOMER package.
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Fig. 6 Overlay of non-coding de novo mutations linked to developmental disorders. a The Deciphering Developmental Disorders (DDD) study included
6139 non-coding regions in its sequence analysis of trios comprising affected individuals and unaffected parents2,32. These non-coding regions were
selected on the basis of high sequence conservation (ultra-conserved elements, UCEs, n= 4307), experimental validation (experimentally validated
enhancers, EVEs, n= 595) or identification as a putative heart enhancer (PHE, n= 1237). Overlap with any H3K27ac, H3K4me3 or H3K27me3 1 kb bins is
shown as an aggregate and for each individual category (UCE, EVE or PHE). b Equivalent overlap is shown for the 739 regions in which disease-associated
de novo mutations (DNMs) were identified. c In total, 46% of DNM-positive regions were situated (+/− 1 kb) in at least one tissue-replicated H3K27ac
and/or H3K4me3 bin. Over half of the disease-associated overlap was covered by the heart/LV (35%) and brain (18%). 75% of the disease-associated
PHE regions were situated within 1 kb of a heart/LV-specific histone mark. d Enrichment in the number of DNMs overlapping (+/− 1 kb) H3K27ac marks
during human organogenesis for individuals with neurodevelopmental (n= 671 cases), cardiac (n= 124 cases), limb (n= 312 cases) and eye (n= 288
cases) phenotypes. The circles represent the observed/expected ratio with asymmetrical error bars showing the 95% confidence limits calculated for a
Poisson distribution (http://ms.mcmaster.ca/peter/s743/poissonalpha.html). For the neurodevelopmental phenotypes, this included analysis against
DNAse hypersensitivity data and H3K27ac data from second trimester fetal brain10.
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promoters reinforced our previous findings based solely on
computational analysis of 5′ flanking regions for the importance
of NR5A1 in the adrenal and HNF4A in the liver15. However, the
integrated sampling of numerous sites uncovered far more
complex patterns of regulation operating across tissues. The
enrichment of PITX1-binding motifs in active regulatory regions
uniquely shared across the limb bud and palate fits with muta-
tions in PITX1 causing limb defects and cleft palate37. Similarly,
GATA4 and GATA6, inferred from regulatory regions shared
uniquely between the heart and pancreas, are the only two TFs
linked to the dual phenotype of cardiac malformation and
monogenic diabetes38,39. Overlaying GWAS data with chromo-
somal conformation studies from older human fetal brain has
prioritised target genes for risk of schizophrenia40. These tech-
niques are yet to be applied at scale in much smaller human
embryonic tissues. However, because we integrated the data from
many tissues we can begin to make correlations of enhancer
activity to target genes over megabase distances (Fig. 7). While
these preliminary correlations are somewhat rudimentary, we
have made them available as tracks on UCSC Genome Browser
because where linked to expression of the same gene, it might
become possible to group individual enhancers into larger clus-
ters to increase statistical power. The latter can be otherwise
limiting when causally linking non-coding elements to develop-
mental disorders.
Deciphering profiles of H3K27me3 alongside other regulatory
marks and expression profiles was informative. We did not
observe bivalent marking of developmental promoters poised for
gene expression before reaching the limits of resolution, at which
gene sets for structures such as mesenchyme and nerves were
common to all tissues. Instead, we discovered that organ-specific
developmental programmes were disallowed in other human
embryonic tissues by active repression at a series of gene pro-
moters. The ontology of these gene sets, including many encoding
TFs, inferred they are an important aspect of ensuring correct cell
fate decisions. This realisation opens up an opportunity for more
rigorous benchmarking of differentiated hPSCs, including
organoids, both for proximity to the intended lineage in how
appropriate gene expression is activated but also against a clearly
defined set of epigenomic features for how undesired cell fates are
avoided.
In summary, we present an integrated atlas of epigenomic
regulation and transcription responsible for human organogen-
esis. We make all datasets freely available alongside analysis
tracks on the UCSC Genome Browser. The uncovering of cryptic
regulatory regions and patterns of regulation across organs arose
because of direct study of human embryonic tissue. The data
complement current international projects such as the Human
Cell Atlas41, by providing greater resolution of regulatory infor-
mation and depth of sequence information. Moreover, our inte-
grated analyses establish a framework for prioritising and
interpreting disease-associated variants discovered by WGS42 and
provide clear routes towards understanding the underlying
mechanisms.
Methods
Sample dissection. Human embryonic material was collected under ethical
approval from the North West Research Ethics Committee (18/NW/0096),
informed consent from all participants and according to the Codes of Practice of
the Human Tissue Authority15. Tissue collection took place on our co-located
clinical academic campus overseen by our research team ensuring immediate
transfer to the laboratory. Material was staged by the Carnegie classification, and
individual tissues and organs were immediately dissected (Supplementary Data 1
and 2). The material collected here for epigenomic analysis was matched to
material isolated for a previous transcriptomic study15, and the dissection process
was identical. In brief, the pancreas, adrenal gland, whole brain, heart, kidney, liver,
limb buds, lung, stomach and anterior two-thirds of the tongue were visible as
discrete organs and tissues. All visible adherent mesenchymes, including capsular
material (adrenal), were removed under a dissecting microscope. The ureter was
removed from the renal pelvis. A window of tissue was removed from the lateral
wall of the left ventricle of the heart. The dissected segment of liver avoided the
developing gall bladder. The trachea was removed where it entered the lung par-
enchyma. The stomach was isolated between the gastro-oesophageal and pyloric
junctions. The palatal shelves were dissected on either side of the midline. The eye
was dissected, and the RPE peeled off mechanically from its posterior surface
(facilitated by the dark pigmentation of the RPE allowing straightforward
visualisation).
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Fig. 7 Neurodevelopmental de novo mutation within brain-specific histone modification correlated to surrounding gene expression. An intergenic G-to-
T de novo mutation (DNM; hg38, chr16:72427838) is shown for a patient with a neurodevelopmental phenotype. Tracks are shown demonstrating
additional human embryonic non-coding transcription (enriched in human embryonic brain), the three epigenomic marks, ENCODE data26 and
conservation amongst vertebrates. The DNM overlaps a brain-specific (dark blue) H3K27ac and small H3K4me3 mark. The highest correlations are shown,
notably to the promotors of ZNF821 (r= 0.92) (dark blue) with anticorrelation (r=−0.65, red) to the adjacent gene, ATXN1L.
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Tissues were gently teased apart before cross-linking in 1% formaldehyde for 10
min at room temperature. Fixation was quenched with 125 mM glycine for 5 min at
room temperature before centrifugation, removal of the supernatant and washing
twice with 1 ml of PBS. The final PBS supernatant was discarded and samples
stored at −80 °C until use (Supplementary Data 1). The sex of tissue from embryos
was determined by PCR for X and Y chromosome-specific primers (Supplementary
Data 9).
Chromatin immunoprecipitation (ChIP), RNA isolation and sequencing. All
ChIPseq datasets were in biological replicate, except for the stomach and tongue
(Supplementary Data 1). Each sample was placed in lysis buffer [10 mM HEPES,
0.5 mM EGTA, 10 mM EDTA, 0.25% Triton X-100 and protease inhibitor cocktail
(Roche)] on ice for 5 min, and nuclei released with ten strokes in a Dounce
homogeniser. Nuclei were pelleted by centrifugation at 700 rcf for 10 min at 4 °C,
and the supernatant discarded. Nuclei were resuspended in ice cold wash buffer
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(10 mM HEPES, 0.5 mM EGTA, 1 mM EDTA, 20 mM NaCl and protease inhibitor
cocktail), then pelleted by centrifugation at 700 rcf for 10 min at 4 °C and the
supernatant discarded. Nuclei were lysed (50 mM Tris-HCl, 10 mM EDTA, 1%
SDS and protease inhibitor cocktail) and sonicated under prior optimised condi-
tions (Diagenode Bioruptor). Sufficient sample was prepared to allow in parallel
immunoprecipitation for H3K4me3, H3K27ac and H3K27me3 to minimise tech-
nical variation. In total, 1 μg of DNA equivalent was used for each pulldown.
Samples were diluted with nine volumes of dilution buffer (16.7 mM Tris-HCL, 1.2
mM EDTA, 167 mM NaCl, 0.01% SDS and 1.1% Triton X-100). In all, 20 μl of
ChIP-grade magnetic beads were washed twice in dilution buffer and incubated
with each sample for 3 h on a tube rotator at 4 °C to preclear the sample. The beads
were separated, and the pre-cleared lysate transferred to a separate tube. The
magnetic bead pellet was discarded. For each histone modification, 3 μg of antibody
(Supplementary Data 2) were added to each sample followed by incubation on a
tube rotator at 4 °C overnight. In all, 30 μl of magnetic beads were washed twice in
immunoprecipitation dilution buffer and incubated with samples for 3 h at 4 °C.
Beads were collected and washed twice with wash buffer A (20 mM Tris-HCl, 2
mM EDTA, 50 mM NaCl, 0.1% SDS and 1% Triton X-100), once with wash buffer
B (10 mM Tris-HCl, 1 mM EDTA, 250 mM LiCl, 1% NP40 and 1% deoxycholate)
and twice with TE buffer (10 mM Tris-HCl and 1 mM EDTA). Beads were then
incubated in elution buffer (1% SDS and 100 mM NaHCO3) for 30 min at 65 °C
and the beads discarded. The resulting samples were incubated with 167 mM NaCl
for 5 h at 65 °C to remove crosslinks followed by 1 h incubation with 14 μg of
proteinase K. The resulting chromatin was then purified (MinElute, QIAGEN).
DNA libraries were constructed according to the TruSeq® ChIP Sample
Preparation Guide (Illumina, Inc.). Briefly, sample DNA (5–10 ng) was blunt-
ended and phosphorylated, and a single “A” nucleotide added to the 3′ ends of the
fragments in preparation for ligation to an adapter with a single base “T” overhang.
Omitting the size-selection step, the ligation products were then PCR-amplified to
enrich for fragments with adapters on both ends. The final purified product was
then quantitated prior to cluster generation on a cBot instrument (Illumina). The
loaded flow cell was sequenced (paired-end) on a HiSeq2500 (Illumina). In total,
ChIPseq was carried out in three batches with hierarchical clustering analysis to
examine for batch effect (Supplementary Fig. 7).
RNAseq for this study has been described previously (Supplementary Data 3)15;
using identical methodology, we added single datasets for pancreas and tongue and
two datasets for lung to create biological transcriptomic replicates for all tissues
(Supplementary Data 3).
Mapping of ChIPseq and RNAseq. The first batch of ChIPseq was mapped ori-
ginally to hg19 using Bowtie 1.0.0 (parameters -m1 -n2 -l28, uniquely mapped reads
only)43 and peaks called using MACS2 (2.0.10.20131216)44 against a common
input sample (derived from all tissues). MACS parameters used were as follows:
band width 300 bp, mfold 5–50 (used in cross-correlation for fragment length
estimation), q-value cut-off 0.05. To prioritise candidate enhancers for transgenic
testing, H3K27ac data from ENCODE (seven cell lines) and NIH Roadmap
(154 samples)10,26 were mapped similarly. Subsequently, all data, including the
external H1 hPSC and adult pancreas data (Fig. 3c), were mapped to hg38 using
STAR (2.4.2a)45. ChIPseq reads were trimmed to 50 bp for consistency, and only
uniquely mapped reads were retained. For ChIPseq, spliced mappings were sup-
pressed by setting the parameter “alignIntronMax” to 1. The full STAR parameters
for ChIPseq were as follows: “–alignIntronMax 1,–seedSearchStartLmax
30,–outSAMattributes All, and–outSAMtype BAM SortedByCoordinate”. GEN-
CODE 25 gene annotations were used for RNAseq mapping and read counting46.
The full STAR parameters for RNA-seq were as follows: “—outSAMattributes
All,–quantMode GeneCounts –out, SAMtype BAM SortedByCoordinate”.
Chromatin and promoter state analysis. Genomic segmentation was performed
using chromHMM (version 1.11)17 under default parameters labelling samples by
tissue and histone modification. The three histone marks allowed for eight segment
states.
Clustered promoter states were identified for an annotated set of 19,791 protein-
coding genes in each tissue using ngs.plot k-mean clustering (version 2.61) on
unnormalized reads for the combined dataset of replicated RNA-seq and ChIPseq for
H3K4me3, H3K27ac and H3K27me321. Default settings allowed for five clusters
based on rank profiles of read counts 3 kb either side of the TSS. The returned clusters
were then classified according to characteristics detected in both replicates into five
major promoter states (Fig. 2): actively repressed (H3K27me3 signal >50% of
maximum and mean transcript counts <10% of maximum); Narrow expressed
[H3K4me3 signal >25% of maximum with >90% of reads downstream of the TSS and
skew >0.65 (measured across 100 equidistant percentiles from TSS to +3 kb); and
mean transcript counts >10% of maximum]; broad expressed (as for narrow
expressed, but with skew <0.65); bidirectional expressed (H3K4me3 signal >25% of
maximum with <90% of reads downstream of the TSS; and mean transcript counts
>10% of maximum); Bi-dir2 (as for bidirectional expressed, but without the
H3K4me3 signal); Expressed2 (H3K4me3 signal >25% of maximum with mean
transcript counts <10% of maximum); and inactive (<25 of maximum for H3K4me3
and H3K27me3 and mean transcript counts <10% of maximum). This approach left
each gene uniquely assigned to one cluster in any tissue. Bi-dir2 was only identified in
RPE (Supplementary Fig. 2). Expressed2 was detected in the lung, liver and brain
(Supplementary Fig. 3). While superficially this category lacked significant
transcription, in fact, total gene-level read counts were very similar to Broad
expressed. However, longer mRNA and longer first introns limited transcript
detection at the TSS (Supplementary Fig. 4). The full listings are in Supplementary
Data 4. The over-representation of TFs in the TSS regions marked with H3K27me3
and featuring CpG islands was assessed on the dataset of 1659 genes encoding all the
TFs compared against the remaining 18,132 non-TF genes using Fisher’s exact test
(two-sided). To search explicitly for bivalency of H3K4me3 and H3K27me3 at gene
promoters, the default parameters of ngs.plot were extended to allow more clusters (7,
10 or 11) as described in the “Results”. This generated a sub-category of H3K27me3
for each tissue that also contained H3K4me3 (Supplementary Figs. 6, 8 and 10).
Alluvial plots were created using the R package Alluvial Diagrams version 0.2-
047 with modification of the R code to reorder the horizontal splines (alluvia)
within each tissue to keep similar colours together.
Annotation set enrichment for genes and genomic regions. Lists of genes from
the associated promoter state were tested for enrichment of annotations using the
xEnricherGenes function from the R package XGR version 1.1.1 under default
parameters48. Background comprised all remaining annotations used in the ngs.plots
either for embryonic tissues (Fig. 3a, b) or from hPSCs through to adult pancreas
(Fig. 3c, d). Pathway annotation and gene set enrichment analysis for the subset of
H3K27me3/H3K4me3 dual-marked promoters in each tissue was undertaken using
ReactomePA (release 3.10) under default parameters, which associates genes to their
known functions based on the REACTOME pathway database49.
Transgenic analysis in zebrafish. A systematic approach identified candidate
enhancers that were human embryo-enriched and tissue-specific. We identified
marks from the first batch of H3K27ac with RPKM ≥ 25 and ≥2.5-fold enrichment
in the human embryo compared to ENCODE (7 cell lines)26 or NIH Roadmap
datasets (154 tissues, including fetal datasets from the second trimester)10; and that
were undetected in the FANTOM5 project27. To filter these embryonic marks for
tissue specificity, an initial dataset was selected at random and peaks called that
were >200 bp. The H3K27ac datasets from other embryonic tissues were then
overlaid sequentially in random order. Only called peaks >200 bp were included.
After each addition, any peaks with <50% overlap between the new and existing
dataset were retained. For those retained regions, overlapping sequence was filtered
out. Once completed, the final set of human embryo-enriched, tissue-specific
sequences were again filtered for regions >200 bp. Re-running the tissue-specificity
algorithm for random addition of datasets resulted in a 99.6% match to the first
analysis. These candidate enhancer regions were filtered for sequence conservation
(PhastCons LOD score >50)50 and correlated with surrounding transcription (≤1
mb in either direction). We manually inspected the remainder for proximity (<1
Fig. 8 Deletion of enhancer upstream of RBM24 disrupts cardiomyocyte differentiation. a Schematic of a 2.4 mb locus on chromosome 6 containing
eight protein-coding genes centred on a cardiac-specific H3K27ac peak (red, broken line box) within the last intron of ATXN1. This enhancer harbours a
DNM from the DDD cohort associated with congenital heart disease2. The histone modification tracks contain datasets from all the colour-coded tissues. b
Fold enrichment in the heart/LV dataset compared with the average across all other tissues for RNAseq read counts of the genes shown in (a). RBM24 and
CAP2 are considerably enriched in the human embryonic heart. c Magnified schematic of the enhancer shown in (a) showing the location of the DNM and
the CRISPR-Cas9 approach for deletion. d EBs from wild-type and enhancer deletion (mutant) hPSCs containing the NKX2-5-GFP reporter. The images
showing nine EBs for wild-type and mutant are after 14 days of the cardiomyocyte differentiation protocol34,35. Size bar, 500 μm. e Box and whisker plot
(box showing 25th−75th percentile and median line with min–max as whiskers) quantifying GFP across all wild-type (n= 29) and mutant EBs (n= 30). f
RT-qPCR for expression of all the protein-coding genes across the 2.4mb locus depicted in (a). Ten different clones were used in three independent
experiments for mutant EBs with ten, ten and nine clones for wild-type control. Error bars represent S.E.M. from the three independent differentiation
experiments (the individual dots). Time points for RT-qPCR were day 0 (undifferentiated hPSCs) and day 14 (cardiomyocyte progenitors34,35). While CAP2
expression appeared reduced, RBM24 was the only gene with significantly lowered expression following deletion of the cardiac-specific enhancer shown
in a). Significance was assessed using a two-tailed Student’s t test (ns, not significant).
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mb) to genes encoding TFs associated with major developmental disorders and
ensured no H3K4me3 or polyadenylated transcription in the immediate vicinity
(i.e., an unannotated promoter). This resulted in 44 candidate enhancers from
which we tested ten. The candidate sequences were first cloned in TOPO vector
using pCR8/GW/TOPO TA cloning kit (cat. no. K252020, Invitrogen Thermo
Fisher Scientific) and then recombined to the reporter vector Minitol2-GwB-
zgata2-GFP-4851 using the Gateway LR clonase II Enzyme mix (cat. no. 11791020,
Invitrogen Thermo Fisher Scientific). The reporter vector contains a robust mid-
brain enhancer as an internal control for transgenesis.
Transgenic fish were generated with the Tol2 transposon/transposase method of
transgenesis52. Danio rerio embryos were collected from natural spawning and
injected in the yolk at the one-cell stage. The injection mixture contained 50 ng/μl
Tol2 transposase mRNA, purified enhancer test vector and 0.05% phenol red. The
concentration of the enhancer test vector was between 15 and 30 ng/μl. Injected
embryos were visualised from 24 hpf to 48 hpf in an Olympus stereomicroscope
coupled to a fluorescence excitation light source in order to detect the pattern of GFP.
Embryos and adults zebrafish were maintained under standard laboratory
conditions. They were manipulated according to Spanish and European regulation.
All protocols used have been approved by the Ethics Committee of the Andalusian
Government (license numbers 450-1839 and 182-41106 for CABD-CSIC-UPO).
Genome binning, normalisation and thresholding. The genome was parsed into
3,087,584 non-overlapping contiguous 1 kb bins to compare ChIPseq profiles
across tissues and replicates. Reads were counted into bins according to their
mapped start position using csaw (version 3.11)53. Reads from mitochondrial and
unplaced chromosome annotations were removed. A further 697 bins were filtered
out for possessing >10,000 reads in all samples or if the mean read count from
input controls was ≥50% of the mean read count of all samples or for being situated
in pericentromeric regions (using table ideogram from UCSC; listed in Supple-
mentary Data 8). For Pearson correlations with the surrounding transcription
binned, read counts were downsampled statistically using subSeq54 weighting each
sample by the value of the 99th percentile.
Downsampling of read counts to the 99th percentile was used to generate the
custom elbow threshold that called bins as marked or not for subsequent
downstream analyses. When read counts were ordered and plotted by rank, the
resulting graph was typically exponential with most bins having zero or very few
reads (below the elbow threshold) and a small number of bins with very high
read counts (above the elbow threshold). The elbow was defined as the point on
the line with the shortest Euclidian distance to the maximum rank intercept with
the x axis. Our code (arseFromElbow) to determine these thresholds from a
vector of counts is available on github55. Phi correlation was used to measure the
agreement between tissue replicates called by the 1 kb binning method compared
to MACS44. Hierarchical clustering of datasets was undertaken to assess
potential batch effect (displayed by heatmap) based on the combined set of the
10,000 most highly ranked bins from each sample. Sets of tissue-specific
(replicated in exactly one tissue) and tissue-selective bins (replicated in a given
tissue and up to a half of all samples) were produced for each embryonic tissue.
EulerGrids showing pattern frequencies of bins across samples were produced
using the function plotEuler56 as an adaptation of a proposal from Reynolds and
colleagues57 on Biostars.org58.
Motif analysis. HOMER v4.9 was used to search for enriched motifs in selected sets
of bins59. For selected 1 kb bins marked with H3K27Ac, the background set was the
remainder of bins with replicated H3K27Ac across all tissues (n= 160,043).
hPSC culture, cardiomyocyte differentiation and enhancer inactivation. NKX2-
5eGFP/w hPSCs (NKX2-5-GFP reporter) were maintained on mouse embryonic
fibroblasts and passaged using TrypLE Select (Thermo Fisher Scientific) with
cardiomyocyte differentiation performed via embryoid body (EB) formation34,60,61;
except for modified concentrations of BMP4 (25 ng/ml) and Activin A (25 ng/ml).
Day 14 EBs were imaged for GFP and then collected into Trizol Reagent (Thermo
Fisher Scientific) for RNA extraction according to the manufacturer’s specifications
followed by treatment with DNaseI Kit (Sigma). First-strand cDNA synthesis and
qPCR were performed using the Tetro cDNA synthesis kit (Bioline) and Power Up
Sybr Green (Invitrogen). Primers for genes in the RBM24 locus are in Supple-
mentary Data 9.
CRISPR-Cas9 guide-RNAs were designed to the cardiac-specific enhancer in
the final intron of ATXN1 using CHOPCHOP62 version 3 (Supplementary Data 9).
Ribonucleoprotein (RNP) complexes targeting flanking sites around the enhancer
locus were made and cotransfected into hPSCs61. Cells were cloned by serial
dilution and screened for enhancer deletion by PCR (Supplementary Data 9). PCR
screening was carried out using Q5 polymerase (NEB) with GC enhancer (98 °C
180 s, 35 cycles of (98 °C 20 s, 62 °C 30 s, 72 °C 90 s), 98 °C 180 s) to confirm
presence of wild-type (1069 bp), heterozygous (401 bp) or deleted (438 bp)
amplicons in clones.
EBs were imaged on an Olympus IX83 inverted microscope and captured using
an Orca ER camera (Hamamatsu) through CellSens software (Olympus). Images
were processed and analysed using Fiji ImageJ with GFP quantified as a proportion
of the total EB area. Montages for bright-field and FITC channels were created
consistently for all EBs using a Gaussian Blur with sigma radius of 5:00, and a
colour threshold:brightness lower limit of 52:255. Regions of interest were mapped
and the relative GFP-positive area quantified. Significance was assessed using two-
tailed Student’s t test.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the findings of this study are available within
the article and its supplementary information files or from the corresponding author
upon reasonable request. ChIPseq and RNA-seq datasets have been deposited in the
European Genome Phenome repository [www.ebi.ac.uk/ega/home] under accession
codes: EGAS00001003738 (RNA-seq), EGAS0001004335 (ChIPseq) and
EGAS00001003163 (study). Supplementary Data 1–3 detail the human embryonic
material contributing to these datasets. To view data in the UCSC genome browser, a
trackhub is at http://www.humandevelopmentalbiology.manchester.ac.uk/. The external
databases were used by the study: ENCODE [www.encodeproject.org/]26; NIH Roadmap
[www.roadmapepigenomics.org/]10; FANTOM5 [fantom.gsc.riken.jp/5/]27;
xEnricherGenes (from XGR v1.1.1)48; Reactome pathway database [reactome.org/]49;
and HOMER v4.9 [homer.ucsd.edu/homer/]59.
Code availability
The following codes are freely available55,56: arseFromElbow [https://rdrr.io/github/
davetgerrard/utilsGerrardDT/src/R/arseFromElbow.R] and plotEuler [https://github.
com/davetgerrard/utilsGerrardDT].
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